BRIEF: WuXi AppTec raises $975 Million through share placement at 6.9% discount
Pharmaceutical outsourcing giant WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) announced on Thursday it will raise HK$7.65 billion ($975 million) by placing around 73.8 million new Hong Kong-listed shares at HK$104.27 per share, representing a 6.9% discount to the stock’s previous closing price of HK$112. The new shares account for about 16.01% of the company’s enlarged capital for its Hong Kong-listed stock and 2.51% of its total issued share capital.
WuXi AppTec said around 90% of the proceeds will be used to accelerate expansion of its global footprint and expand production capacity, while the remaining 10% will go toward general corporate purposes.
The share placement comes shortly after the company reported strong first-half results. Revenue for the six months through June rose 20.64% year-on-year to 20.8 billion yuan, while its net profit surged 95.46% to 8.29 billion yuan.
WuXi AppTec’s stock opened lower on Thursday and closed at HK$107.8 by the midday break, down 3.75%. The stock is up 90% year-to-date.
By Lee Shih Ta
To subscribe to Bamboo Works weekly free newsletter, click here
Related Articles
RELATED ARTICLES
-
WuXi group wrestles with uncertainty over pharma tariffs
2268.HK -
Rising profit at WuXi Biologics underscores drug sector rebound
2269.HK
-
Fortune smiles again on WuXi AppTec with profit surge
2359.HK 603259.SHG
-
BRIEF: SenseTime raises $318 million in share placement at 6.25% discount
0020.HK
-
BRIEF: Dmall raises $50 million in share placement at 10% discount
2586.HK
-
BRIEF: Qunabox raises $41 million in share placement at 17% discount
0917.HK
-
BRIEF: Lancang Ancient Tea to raise $7.5 million via share placement at 16% discount
6911.HK
